Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

872594

registered interest
date	27/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer Drugs Fund
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the timetable is for the publication of the review of the Cancer Drugs Fund.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	134408
answer	answer is ministerial correction date of answer 03/04/2018 answer text <p>A review of the operation of the Cancer Drugs Fund is currently underway. A summary report from this review is anticipated during 2018-19.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 03/04/2018 13:21:04 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

872595

registered interest
date	27/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Immunotherapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what progress has been made on recommendation 32 of the NHS Cancer Strategy, Achieving World Class Outcomes, on the adoption of immunotherapy treatments.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	134409
answer	answer is ministerial correction date of answer 03/04/2018 answer text <p>The development of immunotherapies for the treatment of cancer is an emergent area of clinical practice. The National Institute for Health and Care Excellence has recommended a number of immunotherapies for routine use on the National Health Service, and these are commissioned by NHS England.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 134411 question first answered 03/04/2018 13:20:12 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

872596

registered interest
date	27/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Glaucoma
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what new procedures and operations for treating glaucoma are planned to become available on the NHS; and if he will make a statement.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	134410
answer	answer is ministerial correction date of answer 03/04/2018 answer text <p>The National Institute for Health and Care Excellence (NICE) has recently published interventional procedures guidance on a number of new procedures and is currently developing guidance on another, all for use in the treatment of glaucoma.</p><p>NICE interventional procedures guidance makes recommendations for the National Health Service on whether new operational procedures are sufficiently safe and efficacious for routine use in clinical practice, but does not provide guidance on whether such procedures represent a clinically and cost effective use of NHS resources.</p><p>It is for commissioners locally to decide based on the available evidence whether to fund a procedure recommended in NICE interventional procedures guidance or any other procedure.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 03/04/2018 13:18:29 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

872597

registered interest
date	27/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what progress has been made on implementing recommendation 32 of the NHS Cancer Strategy on the adaptation of immunotheropy treatments.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	134411
answer	answer is ministerial correction date of answer 03/04/2018 answer text <p>The development of immunotherapies for the treatment of cancer is an emergent area of clinical practice. The National Institute for Health and Care Excellence has recommended a number of immunotherapies for routine use on the National Health Service, and these are commissioned by NHS England.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 134409 question first answered 03/04/2018 13:20:12 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

872604

registered interest
date	27/03/2018
answering body	Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	Treasury
hansard heading	Financial Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask Mr Chancellor of the Exchequer, whether his Department plans to contribute to the debate arising from the Financial Conduct Authority's discussion paper, Transforming culture in Financial Services, published on 12 March 2018.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	134418
answer	answer is ministerial correction date of answer 06/04/2018 answer text <p>The Government welcomes the Financial Conduct Authority’s recent discussion paper, ‘Transforming Culture in Financial Services’. The Government has implemented a number of reforms since the financial crisis to improve conduct and encourage a more positive culture in the financial services sector, including through the introduction of the Senior Managers and Certification Regime. The Government will continue to engage with the financial regulators and industry to progress this important issue, including to consider the views raised in this discussion paper.</p> answering member constituency Salisbury answering member printed John Glen question first answered 06/04/2018 08:58:20 answering member 4051 label Biography information for John Glen
tabling member	4131 label Biography information for Jim Shannon

872605

registered interest
date	27/03/2018
answering body	Foreign and Commonwealth Office
answering dept id	16
answering dept short name	Foreign and Commonwealth Office
answering dept sort name	Foreign and Commonwealth Office
hansard heading	Palestinians: Radicalism
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Foreign and Commonwealth Affairs, pursuant to the Answer of 16 March 2018 to Question 132437, whether the culture of honouring people as martyrs within Palestinian society contributes to regional tensions and extremism and retards progress towards peace between Israel and the Palestinians.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	134419
answer	answer is ministerial correction date of answer 06/04/2018 answer text <p>The glorification of terrorists as &quot;martyrs&quot; is a barrier to peace. It is important the Palestinian leadership continue efforts to implement fully the recommendations of the Quartet Report regarding incitement. But we are encouraged by President Abbas and the Palestinian Authority's track record, which shows a commitment to non-violence and a negotiated two-state solution. We have a regular dialogue with both the Palestinian Authority and the Government of Israel in which we reiterate the need for both sides to prepare their populations for peaceful coexistence, including by promoting a more positive portrayal of each other.</p> answering member constituency North East Bedfordshire answering member printed Alistair Burt question first answered 06/04/2018 11:35:54 answering member 1201 label Biography information for Alistair Burt
tabling member	4131 label Biography information for Jim Shannon

872615

registered interest
date	27/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Hygiene
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of automated electronic monitoring of hand gel usage as a means of collecting more accurate data on hand hygiene compliance.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	134429
answer	answer is ministerial correction date of answer 29/03/2018 answer text <p>NHS Improvement is leading work to drive down healthcare associated infections and as part of this have carried out an early assessment of electronic monitoring of hand gel usage. The technology used in some trusts is currently reliant on local data infrastructure and many existing systems would not be able to support it.</p><p> </p><p>It is important to note that automated monitoring of hand gel and soap usage does not address the correct techniques of hand hygiene by healthcare staff. This is important in reducing the spread of infections. NHS Improvement’s work programme for 2018/19 includes a workstream on hand hygiene compliance and monitoring.</p><p> </p><p>We are working with our partners across the health and social care system, including the Care Quality Commission, to ensure that consideration of best practice in hand hygiene policies remains a focus of inspections in acute trusts.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 29/03/2018 15:42:52 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4131 label Biography information for Jim Shannon

872616

registered interest
date	27/03/2018
answering body	Cabinet Office
answering dept id	53
answering dept short name	Cabinet Office
answering dept sort name	Cabinet Office
hansard heading	Breast Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Minister for the Cabinet Office, how many women have been diagnosed with triple negative breast cancer in each of the last five years.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	134430
answer	answer is ministerial correction date of answer 05/04/2018 answer text <p>The information requested falls within the responsibility of the UK Statistics Authority. I have asked the Authority to reply.</p> answering member constituency Norwich North answering member printed Chloe Smith question first answered 05/04/2018 10:13:12 answering member 1609 label Biography information for Chloe Smith attachment 1 file name PQ_134430.pdf title UKSA Response
tabling member	4131 label Biography information for Jim Shannon

872619

registered interest
date	27/03/2018
answering body	Cabinet Office
answering dept id	53
answering dept short name	Cabinet Office
answering dept sort name	Cabinet Office
hansard heading	Brain: Tumours
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Minister for the Cabinet Office, how many people were diagnosed with brain tumours in each of the last five years.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	134433
answer	answer is ministerial correction date of answer 05/04/2018 answer text <p>The information requested falls within the responsibility of the UK Statistics Authority. I have asked the Authority to reply.</p> answering member constituency Norwich North answering member printed Chloe Smith question first answered 05/04/2018 10:11:22 answering member 1609 label Biography information for Chloe Smith attachment 1 file name PQ_134433.pdf title UKSA Response
tabling member	4131 label Biography information for Jim Shannon

872621

registered interest
date	27/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Alzheimer's Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that sufficient funding is available to provide drugs for Alzheimer's disease to patients.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	134435
answer	answer is ministerial correction date of answer 04/04/2018 answer text <p>The Government remains strongly committed to supporting research into dementia and the United Kingdom research community is playing a significant role in the global effort to find a cure or a major disease-modifying treatment by 2025.</p><p>The Government has doubled research spending on dementia, with a commitment to maintain this level of spending of at least £60 million a year to 2020, with an ambition for overall spending on research from all sectors to double by 2025. Much of this investment is in research to better understand the nature of dementia, to inform development of future treatments and ways to prevent the onset of the condition.</p><p>We will need to consider the potential impacts that new and emerging treatments for Alzheimer’s disease may have on the health system. We will engage with initiatives such as Alzheimer’s Research UK’s proposed Taskforce which seek to identify innovative and cooperative solutions for making available future medicines and diagnostic approaches for people living with dementia.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 04/04/2018 14:10:46 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4131 label Biography information for Jim Shannon